Detecting Abnormal Eye Movements in Patients with Neurodegenerative Diseases - Current Insights.

Parkinson disease eye movements eye-tracking technology neurodegenerative diseases parkinsonian disorders

Journal

Eye and brain
ISSN: 1179-2744
Titre abrégé: Eye Brain
Pays: New Zealand
ID NLM: 101587774

Informations de publication

Date de publication:
2024
Historique:
received: 18 10 2023
accepted: 23 03 2024
medline: 15 4 2024
pubmed: 15 4 2024
entrez: 15 4 2024
Statut: epublish

Résumé

This review delineates the ocular motor disturbances across a spectrum of neurodegenerative disorders, including Alzheimer's Disease (AD) and related disorders (ADRD), Parkinson's Disease (PD), atypical parkinsonism, and others, leveraging advancements in eye-tracking technology for enhanced diagnostic precision. We delve into the different classes of eye movements, their clinical assessment, and specific abnormalities manifesting in these diseases, highlighting the nuanced differences and shared patterns. For instance, AD and ADRD are characterized by increased saccadic latencies and instability in fixation, while PD features saccadic hypometria and mild smooth pursuit impairments. Atypical parkinsonism, notably Progressive Supranuclear Palsy (PSP) and Corticobasal Syndrome (CBS), presents with distinct ocular motor signatures such as vertical supranuclear gaze palsy and saccadic apraxia, respectively. Our review underscores the diagnostic value of eye movement analysis in differentiating between these disorders and also posits the existence of underlying common pathological mechanisms. We discuss how eye movements have potential as biomarkers for neurodegenerative diseases but also some of the existing limitations.

Identifiants

pubmed: 38617403
doi: 10.2147/EB.S384769
pii: 384769
pmc: PMC11015840
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

3-16

Informations de copyright

© 2024 Sekar et al.

Déclaration de conflit d'intérêts

Dr Muriel Panouillères is an employee of P3Lab company that develops a medical eyetracking device. The authors report no other conflicts of interest in this work.

Auteurs

Akila Sekar (A)

SENSE Research Unit, Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, UK.

Muriel T N Panouillères (MTN)

NeuroClues, Ottignies-Louvain-la-Neuve, Belgium.
CIAMS, Université Paris-Saclay, Orsay, France.

Diego Kaski (D)

SENSE Research Unit, Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, UK.

Classifications MeSH